Although S1P signalling promotes angiogenesis, specific signalling through S1P2 in endothelial cells and tumour-infiltrating myeloid cells has a counterbalancing effect, inhibiting tumour angiogenesis and tumour growth in vivo through inhibition of VEGF expression and MMP9 activity [123,134]. This evidence concerns the gene MMP9 and neoplasm.